Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Precancerous Conditions 6Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Rectal Neoplasms 1Papillomavirus Infections 1Oropharyngeal Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Liver Neoplasms 1Leukoplakia, Oral 1Infections 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1Anus Neoplasms 1Adenomatous Polyps 1

Interventions

Photochemotherapy 1Gene Expression Profiling 1Dihematoporphyrin Ether 1Celecoxib 1Biopsy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukoplakia, Oral × Gene Expression Profiling × Other neoplasm × Clear all
NCT01238185 2013-08-12

Aspirin Mouthwash in Treating Patients With Oral Leukoplakia

National Cancer Institute (NCI)

Phase 1 Completed
40 enrolled
Head & NeckOther neoplasm

Leukoplakia, Oral, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡